Leukocytoclastic Vasculitis Localized to the Uterine Cervix
Hawai i Journal of health & Social Welfare · 2024
DOI: 10.62547/cxck2854 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hawai i Journal of health & Social Welfare, 2024. Verfasst von Jose G. Roble und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Patients with gynecologic vasculitis should be evaluated for systemic disease as prognosis and treatment can vary depending on systemic involvement versus isolated disease. Leukocytoclastic vasculitis is a rare, immune-mediated small-vessel vasculitis. Leukocytoclastic vasculitis of the uterine cervix with systemic involvement has not previously been reported. A 25-year-old female with abnormal cervical cancer screening presented for colposcopy. Biopsies were notable for dysplasia and concurrent leukocytoclastic vasculitis. The patient later recalled a recurrent rash of her lower extremities, suspicious for systemic disease. Patients with gynecologic vasculitis should be evaluated for systemic involvement because prognosis and treatment differ from that of isolated disease. Additionally, leukocytoclastic vasculitis of the uterine cervix may be associated with both hormonal contraception and infections such as human papillomavirus, and any resulting cervical dysplasia should be monitored for progression and treated accordingly.
Zitieren
APA
Roble, J. G., Ligon, S. E., & Langan, K. L. (2024). Leukocytoclastic Vasculitis Localized to the Uterine Cervix. Hawai i Journal of health & Social Welfare. https://doi.org/10.62547/cxck2854
Vancouver
Roble JG, Ligon SE, Langan KL. Leukocytoclastic Vasculitis Localized to the Uterine Cervix. Hawai i Journal of health & Social Welfare. 2024. doi:10.62547/cxck2854
BibTeX
@article{Roble2024,
author = {Roble, Jose G. and Ligon, Sarah E. and Langan, Kelly L.},
title = {Leukocytoclastic Vasculitis Localized to the Uterine Cervix},
journal = {Hawai i Journal of health & Social Welfare},
year = {2024},
doi = {10.62547/cxck2854}
}
EUVIMED